Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Can Pharmacogenomics Effectively Combat Antimicrobial Resistance?
Did you know that without urgent action, antibiotic resistance could lead to over 10 million deaths annually? This alarming figure highlights the global…
Personalized Approach to Adverse Drug Reactions
Adverse drug reactions (ADRs) pose a substantial challenge within the pharmaceutical sector, with over 106,000 fatalities annually in the United States, according to…
Advancements in Pharmacogenomic Testing: Implications for Drug Development
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
The Role of Pharmacogenomics in Addressing Racial and Ethnic Health Disparities
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in underprivileged communities remains a pressing area…
Assessment of the Clinical Validity of Pharmacogenomics in Pain Management.
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
Lessons from COVID-19: Pharmacogenomics in Preparing for Future Pandemics
The COVID-19 pandemic has posed unprecedented challenges, prompting a critical inquiry: Might our genetic makeup hold the key to more effective treatments in…
What is “Omics” and is Pharmacogenomics a Part of It?
In the realm of medical research, a novel domain has surfaced – “omics.” It encompasses the in-depth study of biological molecules, including genes,…
PGx and the Microbiome: Understanding How Gut Bacteria Influence Drug Response
Explore the synergy between PGx and the Microbiome to unlock the secrets of gut health’s role in shaping personalized drug responses.
PGx-Guided Antiplatelet Therapy: Reducing Bleeding Risks with Personalized Dosing
Unlock personalized dosing for safer antiplatelet therapy with pharmacogenomics, reducing bleeding risks in cardiovascular care.
End of content
End of content